Suellen P. Carvalho

Salvador, BA 40296710, Brazil

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Pleiotropic Effects of Polymorphisms in the BCL11A Gene on Laboratory Parameters in Sickle Cell Anemia.

Pleiotropic Effects of Polymorphisms in the BCL11A Gene on Laboratory Parameters in Sickle Cell Anemia.

Journal: International journal of molecular sciences
Published: September 12, 2025

Leg Ulcers in Sickle Cell Disease: A Multifactorial Analysis Highlights the Hemolytic Profile.

Leg Ulcers in Sickle Cell Disease: A Multifactorial Analysis Highlights the Hemolytic Profile.

Journal: Hematology reports
Published: October 12, 2022

Role of paraoxonase 1 activity and PON1 gene polymorphisms in sickle cell disease.

Role of paraoxonase 1 activity and PON1 gene polymorphisms in sickle cell disease.

Journal: Scientific reports
Published: August 23, 2022

A Description of the Hemolytic Component in Sickle Leg Ulcer: The Role of Circulating miR-199a-5p, miR-144, and miR-126.

A Description of the Hemolytic Component in Sickle Leg Ulcer: The Role of Circulating miR-199a-5p, miR-144, and miR-126.

Journal: Biomolecules
Published: January 04, 2022

TGFBR3 Polymorphisms (rs1805110 and rs7526590) Are Associated with Laboratory Biomarkers and Clinical Manifestations in Sickle Cell Anemia.

TGFBR3 Polymorphisms (rs1805110 and rs7526590) Are Associated with Laboratory Biomarkers and Clinical Manifestations in Sickle Cell Anemia.

Journal: Disease markers
Published: August 03, 2020

Priapism in sickle cell disease: Associations between NOS3 and EDN1 genetic polymorphisms and laboratory biomarkers.

Priapism in sickle cell disease: Associations between NOS3 and EDN1 genetic polymorphisms and laboratory biomarkers.

Journal: PloS one
Published: July 24, 2020

Transforming Growth Factor Beta Receptor 3 Haplotypes in Sickle Cell Disease Are Associated with Lipid Profile and Clinical Manifestations.

Transforming Growth Factor Beta Receptor 3 Haplotypes in Sickle Cell Disease Are Associated with Lipid Profile and Clinical Manifestations.

Journal: Mediators of inflammation
Published: May 24, 2020

Sickle Cell Anemia: Variants in the CYP2D6, CAT, and SLC14A1 Genes Are Associated With Improved Hydroxyurea Response.

Sickle Cell Anemia: Variants in the CYP2D6, CAT, and SLC14A1 Genes Are Associated With Improved Hydroxyurea Response.

Journal: Frontiers in pharmacology
Published: April 17, 2020

Investigation of Lipid Profile and Clinical Manifestations in SCA Children.

Investigation of Lipid Profile and Clinical Manifestations in SCA Children.

Journal: Disease markers
Published: April 07, 2020

Sickle cell disease: A distinction of two most frequent genotypes (HbSS and HbSC).

Sickle cell disease: A distinction of two most frequent genotypes (HbSS and HbSC).

Journal: PloS one
Published: October 21, 2019

Hydroxyurea alters circulating monocyte subsets and dampens its inflammatory potential in sickle cell anemia patients.

Hydroxyurea alters circulating monocyte subsets and dampens its inflammatory potential in sickle cell anemia patients.

Journal: Scientific reports
Published: April 05, 2019

Hydroxyurea alters hematological, biochemical and inflammatory biomarkers in Brazilian children with SCA: Investigating associations with βS haplotype and α-thalassemia.

Hydroxyurea alters hematological, biochemical and inflammatory biomarkers in Brazilian children with SCA: Investigating associations with βS haplotype and α-thalassemia.

Journal: PloS one
Published: January 05, 2019
Showing 1-12 of 15

Last Updated: 09/26/2026